2nd Circuit: Summary Judgment In Favor Of Plan Was Proper
NEW YORK — Allegations that a non-Hodgkin’s lymphoma patient was unfairly denied coverage by her insurer for the immune-boosting drug Gamunex were properly rejected on summary judgment, the Second Circuit U.S....To view the full article, register now.
Already a subscriber? Click here to view full article